Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Fellow in Cardiology, Medicine, Duke University 2001 - 2002
  • M.H.S., Duke University 2001
  • Fellow in Cardiology, Medicine, Duke University 1997 - 2000
  • Medical Resident, Medicine`, University of Pennsylvania 1994 - 1997
  • M.D., Washington University in St. Louis 1994
• 

  Previous Appointments & Affiliations

  • Assistant Consulting Professor of Medicine, Medicine, Cardiology, Medicine 2005 - 2009
  • Assistant Professor of Medicine, Medicine, Cardiology, Medicine 2002 - 2004
  • Instructor, Temporary in the Department of Medicine, Medicine, Cardiology, Medicine 2002
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Whellan, David J. “Look After You Leap.” Jacc Heart Fail 9, no. 12 (December 2021): 925–26. https://doi.org/10.1016/j.jchf.2021.09.003.
       Full Text  Link to Item
    • Whellan, David J., and Christopher M. O’Connor. “Function Follows Form.” Jacc Heart Fail 9, no. 7 (July 2021): 482–83. https://doi.org/10.1016/j.jchf.2021.02.012.
       Full Text  Link to Item
    • Pastva, Amy M., Pamela W. Duncan, Gordon R. Reeves, M Benjamin Nelson, David J. Whellan, Christopher M. O’Connor, Joel D. Eggebeen, et al. “Strategies for supporting intervention fidelity in the rehabilitation therapy in older acute heart failure patients (REHAB-HF) trial.” Contemp Clin Trials 64 (January 2018): 118–27. https://doi.org/10.1016/j.cct.2017.10.014.
       Full Text  Link to Item
    • Whellan, David J. “Change Is Not Always Good.” J Am Coll Cardiol 70, no. 20 (November 14, 2017): 2501–3. https://doi.org/10.1016/j.jacc.2017.09.1067.
       Full Text  Link to Item
    • Whellan, David J., and JoAnn Lindenfeld. “Easy to Predict, Difficult to Prevent.” Jacc Heart Fail 5, no. 3 (March 2017): 226–28. https://doi.org/10.1016/j.jchf.2017.01.006.
       Full Text  Link to Item
    • Whellan, David J., Melissa M. McCarey, Bradley S. Taylor, Todd K. Rosengart, Amelia S. Wallace, A Laurie W. Shroyer, James S. Gammie, and Eric D. Peterson. “Trends in Robotic-Assisted Coronary Artery Bypass Grafts: A Study of The Society of Thoracic Surgeons Adult Cardiac Surgery Database, 2006 to 2012.” Ann Thorac Surg 102, no. 1 (July 2016): 140–46. https://doi.org/10.1016/j.athoracsur.2015.12.059.
       Full Text  Link to Item
    • Whellan, David J., Amanda Stebbins, Adrian F. Hernandez, Justin A. Ezekowitz, John J. V. McMurray, Paul J. Mather, Vic Hasselblad, and Christopher M. O’Connor. “Dichotomous Relationship Between Age and 30-Day Death or Rehospitalization in Heart Failure Patients Admitted With Acute Decompensated Heart Failure: Results From the ASCEND-HF Trial.” J Card Fail 22, no. 6 (June 2016): 409–16. https://doi.org/10.1016/j.cardfail.2016.02.011.
       Full Text  Link to Item
    • Ragupathi, L., N. Fonseka, J. A. Sendecki, M. M. McCarey, S. W. Breecker, and D. J. Whellan. “Proton pump inhibitors and hypomagnesemia in patients with arrhythmias.” Int J Clin Pract 69, no. 12 (December 2015): 1525–26. https://doi.org/10.1111/ijcp.12710.
       Full Text  Link to Item
    • Bellam, Naveen, Anita A. Kelkar, and David J. Whellan. “Team-Based Care for Managing Cardiac Comorbidities in Heart Failure.” Heart Fail Clin 11, no. 3 (July 2015): 407–17. https://doi.org/10.1016/j.hfc.2015.03.005.
       Full Text  Link to Item
    • Whellan, David J., William E. Kraus, Dalane W. Kitzman, Bridget Rooney, Steven J. Keteyian, Ileana L. Piña, Stephen J. Ellis, et al. “Authorship in a multicenter clinical trial: The Heart Failure-A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) Authorship and Publication (HAP) scoring system results.” Am Heart J 169, no. 4 (April 2015): 457-63.e6. https://doi.org/10.1016/j.ahj.2014.11.022.
       Full Text  Link to Item
    • Whellan, David J., Jay L. Goldstein, Byron L. Cryer, Glenn M. Eisen, Angel Lanas, Alan B. Miller, James M. Scheiman, John G. Fort, Ying Zhang, and Christopher O’Connor. “PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: results of two 6-month, phase 3 studies.” Am Heart J 168, no. 4 (October 2014): 495-502.e4. https://doi.org/10.1016/j.ahj.2014.05.017.
       Full Text  Link to Item
    • Whellan, David J., Shantanu Sarkar, Jodi Koehler, Roy S. Small, Andrew Boyle, Eduardo N. Warman, and William T. Abraham. “Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics.” Am J Cardiol 111, no. 1 (January 1, 2013): 79–84. https://doi.org/10.1016/j.amjcard.2012.08.050.
       Full Text  Link to Item
    • Whellan, David J., Margueritte Cox, Adrian F. Hernandez, Paul A. Heidenreich, Lesley H. Curtis, Eric D. Peterson, and Gregg C. Fonarow. “Utilization of hospice and predicted mortality risk among older patients hospitalized with heart failure: findings from GWTG-HF.” J Card Fail 18, no. 6 (June 2012): 471–77. https://doi.org/10.1016/j.cardfail.2012.02.006.
       Full Text  Link to Item
    • Whellan, David J., Christopher J. Droogan, James Fitzpatrick, Suzanne Adams, Melissa M. McCarey, Jocelyn Andrel, Paul Mather, Sharon Rubin, Raphael Bonita, and Scott Keith. “Change in intrathoracic impedance measures during acute decompensated heart failure admission: results from the Diagnostic Data for Discharge in Heart Failure Patients (3D-HF) Pilot Study.” J Card Fail 18, no. 2 (February 2012): 107–12. https://doi.org/10.1016/j.cardfail.2011.10.017.
       Full Text  Link to Item
    • Whellan, David J., Anil Nigam, Malcolm Arnold, Aijing Z. Starr, James Hill, Gerald Fletcher, Stephen J. Ellis, et al. “Benefit of exercise therapy for systolic heart failure in relation to disease severity and etiology-findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training study.” Am Heart J 162, no. 6 (December 2011): 1003–10. https://doi.org/10.1016/j.ahj.2011.09.017.
       Full Text  Link to Item
    • Whellan, David J., Suzanne Adams, and Lisa Bowerman. “Review of advanced heart failure device diagnostics examined in clinical trials and the potential benefit from monitoring capabilities.” Prog Cardiovasc Dis 54, no. 2 (September 2011): 107–14. https://doi.org/10.1016/j.pcad.2011.06.001.
       Full Text  Link to Item
    • Whellan, David J., Xin Zhao, Adrian F. Hernandez, Li Liang, Eric D. Peterson, Deepak L. Bhatt, Paul A. Heidenreich, Lee H. Schwamm, and Gregg C. Fonarow. “Predictors of hospital length of stay in heart failure: findings from Get With the Guidelines.” J Card Fail 17, no. 8 (August 2011): 649–56. https://doi.org/10.1016/j.cardfail.2011.04.005.
       Full Text  Link to Item
    • Whellan, David J., Kevin T. Ousdigian, Sana M. Al-Khatib, Wenji Pu, Shantanu Sarkar, Charles B. Porter, Behzad B. Pavri, Christopher M. O’Connor, and Christopher M. PARTNERS Study Investigators. “Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.” J Am Coll Cardiol 55, no. 17 (April 27, 2010): 1803–10. https://doi.org/10.1016/j.jacc.2009.11.089.
       Full Text  Link to Item
    • Whellan, David J., Melissa A. Greiner, Kevin A. Schulman, and Lesley H. Curtis. “Costs of inpatient care among Medicare beneficiaries with heart failure, 2001 to 2004.” Circ Cardiovasc Qual Outcomes 3, no. 1 (January 2010): 33–40. https://doi.org/10.1161/CIRCOUTCOMES.109.854760.
       Full Text  Link to Item
    • Whellan, D. J., C. L. Green, J. P. Piccini, and M. W. Krucoff. “QT as a safety biomarker in drug development.” Clin Pharmacol Ther 86, no. 1 (July 2009): 101–4. https://doi.org/10.1038/clpt.2009.70.
       Full Text  Link to Item
    • Whellan, David J. “Introduction: Vasopressin therapy.” Heart Fail Rev 14, no. 2 (June 2009): 57–58. https://doi.org/10.1007/s10741-008-9116-8.
       Full Text  Link to Item
    • Whellan, David J., Christopher M. O’Connor, Kevin T. Ousdigian, Te-Hsin Lung, and Te-Hsin PARTNERS HF Study Investigators. “Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate CorRelation to Symptoms in Patients with Heart Failure (PARTNERS HF).” Am Heart J 156, no. 5 (November 2008): 833-839.e2. https://doi.org/10.1016/j.ahj.2008.06.036.
       Full Text  Link to Item
    • Whellan, David J., and Colleen Harrington. “Diastolic heart failure and continuous hemodynamic monitoring.” Am Heart J 153, no. 4 Suppl (April 2007): 6–11. https://doi.org/10.1016/j.ahj.2007.01.022.
       Full Text  Link to Item
    • Whellan, David J., Christopher M. O’Connor, Kerry L. Lee, Steven J. Keteyian, Lawton S. Cooper, Stephen J. Ellis, Eric S. Leifer, et al. “Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale.” Am Heart J 153, no. 2 (February 2007): 201–11. https://doi.org/10.1016/j.ahj.2006.11.007.
       Full Text  Link to Item
    • Whellan, David J., Shelby D. Reed, Lawrence Liao, Stuart D. Gould, Christopher M. O’connor, and Kevin A. Schulman. “Financial implications of a model heart failure disease management program for providers, hospital, healthcare systems, and payer perspectives.” Am J Cardiol 99, no. 2 (January 15, 2007): 256–60. https://doi.org/10.1016/j.amjcard.2006.08.019.
       Full Text  Link to Item
    • Whellan, David J., Vic Hasselblad, Eric Peterson, Christopher M. O’Connor, and Kevin A. Schulman. “Metaanalysis and review of heart failure disease management randomized controlled clinical trials.” Am Heart J 149, no. 4 (April 2005): 722–29. https://doi.org/10.1016/j.ahj.2004.09.023.
       Full Text  Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.